How a Milk-Derived Peptide Kills Gram-Negative Bacteria by Changing Its Shape
Bovine lactoferricin fights four types of Gram-negative bacteria by transforming its molecular structure through disulfide bond formation.
Quick Facts
What This Study Found
The intramolecular disulfide bond in bovine lactoferricin transforms its molecular structure, which is essential for its antibacterial activity against four Gram-negative pathogenic bacteria.
Key Numbers
Three variants: native Lfcin, Lfcin with disulfide bond (Lfcin DB), and mutant without disulfide bond (Lfcin C36G). Structural analysis by circular dichroism and AlphaFold3 prediction. Tested against four Gram-negative pathogens.
How They Did This
In vitro study synthesizing bovine lactoferricin variants with and without disulfide bonds, testing antibacterial activity against four Gram-negative pathogens, and characterizing structural changes.
Why This Research Matters
Understanding how structural changes enable antimicrobial activity helps scientists design more effective peptide antibiotics, potentially overcoming the growing threat of antibiotic-resistant Gram-negative infections.
The Bigger Picture
Milk-derived peptides represent a natural source of antimicrobials. Understanding the structure-activity relationship of lactoferricin could guide the design of new peptide therapeutics and food preservation agents.
What This Study Doesn't Tell Us
In vitro study — antibacterial activity in a test tube may not translate to efficacy in living organisms. Bioavailability and stability in the body remain to be tested.
Questions This Raises
- ?Can lactoferricin structure be engineered for enhanced potency against specific resistant bacteria?
- ?Would oral lactoferricin survive digestion and remain antimicrobially active?
Trust & Context
- Key Stat:
- 4 Gram-negative bacteria killed Bovine lactoferricin with its disulfide-bonded structure was effective against four pathogenic bacterial species
- Evidence Grade:
- In vitro laboratory study providing mechanistic insight into peptide antimicrobial activity. Clinical relevance depends on future in vivo testing.
- Study Age:
- Published in 2025, advancing understanding of milk-derived antimicrobial peptide mechanisms.
- Original Title:
- Bovine lactoferricin exerts antibacterial activity against four Gram-negative pathogenic bacteria by transforming its molecular structure.
- Published In:
- Frontiers in cellular and infection microbiology, 15, 1508895 (2025)
- Authors:
- Pei, Jie(3), Xiong, Lin(3), Wu, Xiaoyun, Chu, Min, Bao, Pengjia, Ge, Qianyun, Guo, Xian
- Database ID:
- RPEP-13001
Evidence Hierarchy
Frequently Asked Questions
What is lactoferricin?
Lactoferricin is a small antimicrobial peptide found within lactoferrin, a protein naturally present in milk. It serves as the antimicrobial "active center" of the larger protein and can kill bacteria by disrupting their cell membranes.
Could lactoferricin replace antibiotics?
It shows promise as a potential alternative for certain infections, particularly against Gram-negative bacteria that are increasingly antibiotic-resistant. However, challenges like stability and delivery need to be solved before clinical use.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-13001APA
Pei, Jie; Xiong, Lin; Wu, Xiaoyun; Chu, Min; Bao, Pengjia; Ge, Qianyun; Guo, Xian. (2025). Bovine lactoferricin exerts antibacterial activity against four Gram-negative pathogenic bacteria by transforming its molecular structure.. Frontiers in cellular and infection microbiology, 15, 1508895. https://doi.org/10.3389/fcimb.2025.1508895
MLA
Pei, Jie, et al. "Bovine lactoferricin exerts antibacterial activity against four Gram-negative pathogenic bacteria by transforming its molecular structure.." Frontiers in cellular and infection microbiology, 2025. https://doi.org/10.3389/fcimb.2025.1508895
RethinkPeptides
RethinkPeptides Research Database. "Bovine lactoferricin exerts antibacterial activity against f..." RPEP-13001. Retrieved from https://rethinkpeptides.com/research/pei-2025-bovine-lactoferricin-exerts-antibacterial
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.